APOLIPOPROTEIN E (APOE) GENE POLYMORPHISMS AND THEIR ASSOCIATION WITH CARDIOVASCULAR DISEASE (CVD) IN TYPE 2 DIABETES MELLITUS (T2DM)
Received 2023-06-26; Accepted 2023-09-06; Published 2024-01-11
DOI:
https://doi.org/10.22452/jummec.vol27no1.20Keywords:
ApolipoproteinE, apoE, lipid, LDL, diabetes mellitus, T2DM, heart disease, CVDAbstract
Apolipoprotein E (ApoE) is well known for its crucial role in lipid metabolism and is associated with an increased risk of cardiovascular disease (CVD) among subjects with type 2 diabetes mellitus (T2DM). Various apolipoprotein gene families have been determined, including APO (A-I), APO (A-II), APO (A-IV), APO (C-1), APO (C-II), APO (C-III), and APOE. A total of 3,597 nucleotides are encoded by the APOE gene, with four exons and three introns, constituting a polypeptide with 299 amino acids. The current study embarks on linking APOE gene polymorphisms with CVD among patients diagnosed with T2DM. This cross-sectional study involved 101 subjects with specific inclusion and exclusion criteria. The participants were separated into two groups, T2DM (n = 59) and T2DM with CVD (n = 42). Comparative analyses of clinical and biochemical characteristics were performed using student’s t-test and Pearson’s chi-square test (x2). Univariate and multivariate analyses were applied to establish the relationship between APOE gene polymorphisms with ischemic heart disease. The ε3/ε3 genotype was the most prevalent among both groups. The ε3/ε3 genotype (AOR= 0.052; 95% CI = 0.003-0.792; p = 0.033), ε3 allele (AOR = 34.83; 95% CI = 1.118-1085.134; p = 0.043), systolic blood pressure (SBP) (AOR = 1.046; 95% CI = 1.002-1.091; p = 0.042), and HbA1c (AOR = 2.286; 95% CI = 1.577-3.314; p < 0.001) were significantly associated with CVD. The ε3/ε3 genotype was also significantly associated with the lipid parameter, low density lipoprotein cholesterol (LDLc) (p = 0.011). Most T2DM patients presented with ε3 allele which may affect lipid profiles and the risk of CVD disease. This highlights the need to establish APOE as a likely predictive gene for CVD disease in T2DM subjects.
Downloads
Downloads
Published
Issue
Section
License
All authors agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0 to allow others to freely access, copy and use research provided the author is correctly attributed, unless otherwise stated. All articles are available online without charge or other barriers to access. However, anyone wishing to reproduce large quantities of an article (250+) should inform the publisher. Any opinion expressed in the articles are those of the authors and do not reflect that of the University of Malaya, 50603 Kuala Lumpur, Malaysia.